Results 31 to 40 of about 1,423 (197)

Diagnostic Dilemma: An Atypical Case of Astrocytoma in a Patient with Relapsing–Remitting Multiple Sclerosis

Neurology International, 2021
Distinguishing between tumefactive demyelinating lesions (TDLs) and brain tumors in multiple sclerosis (MS) can be challenging. A progressive course is highly common with brain tumors in MS and no single neuroimaging technique is foolproof when ...
Chantal Kahovec, Aman Saini, Michael C. Levin   +2 more
doaj   +1 more source

Cerebrospinal fluid kappa free light chains in patients with tumefactive demyelination. [PDF]

Clin Chem Lab Med
Banks SA, Willrich MAV, Eckel-Passow JE, Tobin WO.   +3 more
europepmc   +2 more sources

Baló Concentric Sclerosis Mimicking Encephalitis with Seizures and Progressive Aphasia in a 26-Year-Old Woman: A Challenging Diagnostic Dilemma

Case Reports in Neurology, 2023
Introduction: Baló’s concentric sclerosis (BCS) is a rare subtype of multiple sclerosis characterized by inflammatory demyelination within the central nervous system.
Nexhmedin Shala, Ilir Tolaj, Fisnik Jashari, Edita Malazogu, Argjend Shala, Gentiant Bajraktari, Ilir Ahmetgjekaj, Shemsedin Dreshaj   +7 more
doaj   +1 more source

MR Perfusion Imaging as a Problem-solving Tool for Differentiating High-grade Glioma and Tumefactive Demyelination: A Report of Two Cases [PDF]

International Journal of Anatomy Radiology and Surgery, 2023
Clinically, it is nearly impossible to differentiate between high-grade glioma, specifically Glioblastoma Multiforme (GBM), and Tumefactive Demyelination (TMD).
Chirag Rajnikant Patel, Varsha Rangankar, Sanjay Khaladkar   +2 more
doaj   +1 more source

Using iron oxide nanoparticles to diagnose CNS inflammatory diseases and PCNSL [PDF]

, 2013
OBJECTIVE: The study goal was to assess the benefits and potential limitations in the use of ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles in the MRI diagnosis of CNS inflammatory diseases and primary CNS lymphoma.
Doolittle, Nancy D., Dósa, Edit, Farrell, Brian T., Frenkel, Eugene P., Gahramanov, Seymur, Hamilton, Bronwyn E., Jacobs, Paula M., Lacy, Cynthia A., Nasseri, Morad, Neuwelt, Edward A., Rimely, Endre   +10 more
core   +1 more source

Baló’s concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures [PDF]

, 2018
Background: Baló’s concentric sclerosis (BCS) is a rare inflammatory demyelinating disorder of the central nervous system characterised by concentric layers of demyelination.
Behrens, J. R., Haas, J., Jarius, S., Paul, F., Wanner, J., Wildemann, B., Würthwein, C.   +6 more
core   +3 more sources

Alemtuzumab use in neuromyelitis optica spectrum disorders: a brief case series. [PDF]

, 2016
Alemtuzumab is an anti-CD52 monoclonal antibody recently licensed for use in relapsing-remitting multiple sclerosis. Here, we report our experience of its use in neuromyelitis optica (NMO) spectrum disorders.
Azzopardi, L, Coles, AJ, Cox, AL, Jones, JL, McCarthy, CL   +4 more
core   +1 more source

Tumefactive demyelinating lesion

Journal of Postgraduate Medicine, 2010
Tumefactive demyelinating lesion, a variant of multiple sclerosis, is a solitary large demyelinating lesion, which mimics cerebral neoplasm. Distinguishing tumefactive lesions from other etiologies of intracranial space-occupying lesions is essential to avoid inadvertent surgical or toxic chemotherapeutic interventions.
Sinha, M. K., Garg, R. K., Bhatt, M. L. B., Chandra, A.   +3 more
openaire   +3 more sources

Deep Learning With Data Enhancement for the Differentiation of Solitary and Multiple Cerebral Glioblastoma, Lymphoma, and Tumefactive Demyelinating Lesion

Frontiers in Oncology, 2021
ObjectivesTo explore the MRI-based differential diagnosis of deep learning with data enhancement for cerebral glioblastoma (GBM), primary central nervous system lymphoma (PCNSL), and tumefactive demyelinating lesion (TDL).Materials and MethodsThis ...
Yu Zhang, Yu Zhang, Kewei Liang, Kewei Liang, Kewei Liang, Jiaqi He, Jiaqi He, He Ma, Hongyan Chen, Fei Zheng, Lingling Zhang, Xinsheng Wang, Xibo Ma, Xibo Ma, Xuzhu Chen   +14 more
doaj   +1 more source

Cerebral tumefactive demyelinating lesions

Oncology Letters, 2015
Tumefactive demyelinating lesions (TDLs), are a rare demyelinating pathological disease in the central neurological system, which have been proven to be a diagnostic dilemma to neurosurgeons. The clinical presentation and radiographic appearance of these lesions often results in their misdiagnosis as intracranial tumors, such as gliomas, which leads to
Wei, Qi, G E, Jia, Xinsheng, Wang, Maozhi, Zhang, Zhenyu, Ma   +4 more
openaire   +3 more sources